Selexipag vs placeboAll‐cause mortality · pulmonary arterial hypertension1 finding from 1 reviewProstacyclin for pulmonary arterial hypertension 2019 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 1199 participantsModerate